North Shore-LIJ Hospitals Rated as Best in Consumer Reports
Two hospitals that are part of the North Shore-LIJ Health System were just rated among the nation’s best performing facilities in New York and nationwide for their prevention of central-line infections in their ICUs. These results come from an in-depth study by Consumer Reports after their analysis of central line infection data from 926 hospitals in 43 states in 2008, including 112 in New York State.
According to the study results, Glen Cove Hospital had a zero infection rate for 1,731 central line days and Southside Hospital was infection-free for 2,565 central line days.
“The North Shore-LIJ Health System has a zero tolerance for preventable hospital-associated infections,” said Kenneth Abrams, MD, the health system’s senior vice president of clinical operations. Certainly, the Consumer Reports study is good news for the North-Shore LIJ Health System, where Corey Ribotsky is a member of the Board of Trustees.
Get Fit and Fundraise
The Leukemia & Lymphoma Society has one of the most creative and lucrative fundraising efforts ever seen. Their Team In Training program has, to date, raised over $1 billion to support blood cancer research and patient services.
This is one example of the many fundraising efforts that LLS conducts. Support from individuals like Corey Ribotsky enabled them to continue their important research efforts.
For more than 21 years now, TNT has offered cerfitied coaches to train and educate participants. Destinations for the half marathons, marathons, triathlons, 100 mile bike rides and more include Tahoe, Honolulu, Anchorage, San Diego, Chicago, Yosemite, Grand Canyon and more.
Since 1949, LLS has invested more than $680 million in research targeted to fighting leukemia, lymphoma and myeloma.
The NIR Group of Roslyn, New York
Corey Ribotsky is the Managing Member of the NIR Group, an Alternative Asset Management Firm based in Roslyn, Long Island. The principals are also investors in the firm’s strategies, assuring that there is no conflict of interest and reassuring investors and building confidence among investors in NIR Group’s ability to realize higher than average returns while simultaneously minimizing the downside risk.